Dissecting the early steps of MLL induced leukaemogenic transformation using a mouse model of AML
The oncogene MLL is frequently translocated in leukemia, resulting in oncogenic fusion proteins. Here, the authors report a temporally controlled mouse model of MLL-ENL driven leukemia AND identify therapeutic targets associated with early MLL-ENL driven leukaemogenesis.
Saved in:
Main Authors: | Silvia Basilico, Xiaonan Wang, Alison Kennedy, Konstantinos Tzelepis, George Giotopoulos, Sarah J. Kinston, Pedro M. Quiros, Kim Wong, David J. Adams, Larissa S. Carnevalli, Brian J. P. Huntly, George S. Vassiliou, Fernando J. Calero-Nieto, Berthold Göttgens |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/f3f11e1f04f14988aa6abc97b3c99275 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML
by: Yue Sheng, et al.
Published: (2020) -
Selective binding of the PHD6 finger of MLL4 to histone H4K16ac links MLL4 and MOF
by: Yi Zhang, et al.
Published: (2019) -
TARGETED THERAPY IN AML TREATMENT
by: Giovanni Martinelli
Published: (2021) -
MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing.
by: Claudia V Andreu-Vieyra, et al.
Published: (2010) -
AKT signaling as a novel factor associated with in vitro resistance of human AML to gemtuzumab ozogamicin.
by: David B Rosen, et al.
Published: (2013)